Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 2

1.

[((18)F)-fluorodeoxyglucose PET/CT in cervix cancer: lymph node assessment and prognostic/predictive value of primary tumour analysis].

Leseur J, Devillers A, Williaume D, Le Prisé E, Fougerou C, Bouriel C, Levêque J, Monpetit E, Blanchot J, de Crevoisier R, Garin E.

Cancer Radiother. 2011 Dec;15(8):699-708. doi: 10.1016/j.canrad.2011.05.013. Epub 2011 Nov 21. French.

PMID:
22104953
[PubMed - indexed for MEDLINE]
2.

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.

Collette S, Collette L, Budiharto T, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad W, Mueller RP, Kurtz J, Morgan DA, Dubois JB, Salamon E, Mirimanoff R, Bolla M, Van der Hulst M, Wárlám-Rodenhuis CC, Bartelink H; EORTC Radiation Oncology Group.

Eur J Cancer. 2008 Nov;44(17):2587-99. doi: 10.1016/j.ejca.2008.07.032. Epub 2008 Aug 29. Erratum in: Eur J Cancer. 2009 Jul;45(11):2061.

PMID:
18757193
[PubMed - indexed for MEDLINE]

Supplemental Content

Loading ...
Write to the Help Desk